Condition: Atrial Fibrillation · Maze Procedure · Sponsor: Pulse Biosciences, Inc.
The primary objective of this Pivotal study is to demonstrate the safety and effectiveness of the Pulse Biosciences nsPFA™ Cardiac Surgery System in treating atrial fibrillation during concomitant cardiac surgical procedures.
This description comes directly from the study's public registry record.
Shweta Kalpa, MD · (800) 543-3695 · Shweta.Kalpa@pulsebiosciences.com
William A. Knape · (919) 757-2033 · bknape@pulsebiosciences.com
Always discuss trial participation with your own doctor first.
| Adventist Heart Institute: Adventist Health St. Helena | St. Helena, California, United States | Recruiting |
| Cardiac Surgery Clinic | Frankel Cardiovascular Center | Ann Arbor, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06959121